A study titled "The Prophylactic Role of Tranexamic Acid in Reducing Blood Loss During Cesarean Delivery: A Prospective Randomized Controlled Trial" was published on July 1, 2026. The publication appeared in the journal Cureus. It is listed as a prospective randomized controlled trial. Carbetocin remains classified as an unapproved compound for research purposes. No findings, results, or outcome data from this publication have been provided beyond its title, journal, and publication date. No details about study design specifics, participant numbers, or comparative results are included in the available event data. This brief reports only the existence and metadata of the publication as recorded. Readers interested in learning more about carbetocin, including its regulatory status and general background, can consult the compound overview for additional context.
Publication on Tranexamic Acid in Cesarean Delivery Mentions Carbetocin Context
See the full carbetocin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42540384/